These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35092582)

  • 1. Clinical and microbiological characteristics of bloodstream infections caused by Enterococcus spp. within internal medicine wards: a two-year single-centre experience.
    Lupia T; Roberto G; Scaglione L; Shbaklo N; De Benedetto I; Scabini S; Mornese Pinna S; Curtoni A; Cavallo R; De Rosa FG; Corcione S
    Intern Emerg Med; 2022 Jun; 17(4):1129-1137. PubMed ID: 35092582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
    Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
    Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.
    Suzuki H; Hase R; Otsuka Y; Hosokawa N
    J Infect Chemother; 2017 Jun; 23(6):390-393. PubMed ID: 28385565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.
    Aamodt H; Mohn SC; Maselle S; Manji KP; Willems R; Jureen R; Langeland N; Blomberg B
    BMC Infect Dis; 2015 Feb; 15():107. PubMed ID: 25884316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Vancomycin or Beta-Lactam Therapy in Ampicillin-Susceptible
    Fletcher JM; Kram SJ; Sarubbi CB; Anderson DJ; Kram BL
    J Pharm Pract; 2019 Aug; 32(4):375-381. PubMed ID: 29310494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study.
    Billington EO; Phang SH; Gregson DB; Pitout JD; Ross T; Church DL; Laupland KB; Parkins MD
    Int J Infect Dis; 2014 Sep; 26():76-82. PubMed ID: 24813873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project.
    Mussa M; Martínez Pérez-Crespo PM; Lopez-Cortes LE; Retamar-Gentil P; Sousa-Dominguez A; Goikoetxea-Aguirre AJ; Reguera-Iglesias JM; León Jiménez E; Fernández-Natal I; Armiñanzas-Castillo C; Boix-Palop L; Cuquet-Pedragosa J; Morán Rodríguez MÁ; Fernandez-Suarez J; Del Arco-Jiménez A; Jóver-Saenz A; Bahamonde-Carrasco A; Galan-Sanchez F; Sánchez-Calvo JM; Smithson-Amat A; Vinuesa-García D; Sánchez-Porto A; López-Hernández I; Rodríguez-Baño J;
    Microbiol Spectr; 2022 Aug; 10(4):e0005122. PubMed ID: 35771010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of vancomycin resistance in Enterococcus faecium bloodstream infection on mortality: A retrospective analysis of nationwide surveillance data.
    Huh K; Chung DR; Ha YE; Ko JH; Huh HJ; Lee NY; Cho SY; Kang CI; Peck KR; Song JH;
    Int J Infect Dis; 2023 Sep; 134():8-14. PubMed ID: 37172775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan.
    Chou CH; Lee NY; Lee HC; Chang CM; Lee CC; Ko WC
    J Microbiol Immunol Infect; 2012 Jun; 45(3):221-7. PubMed ID: 22578639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting.
    Xie O; Slavin MA; Teh BW; Bajel A; Douglas AP; Worth LJ
    BMC Infect Dis; 2020 Mar; 20(1):228. PubMed ID: 32188401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series.
    Giacobbe DR; Labate L; Tutino S; Baldi F; Russo C; Robba C; Ball L; Dettori S; Marchese A; Dentone C; Magnasco L; Crea F; Willison E; Briano F; Battaglini D; Patroniti N; Brunetti I; Pelosi P; Bassetti M
    Ann Med; 2021 Dec; 53(1):1779-1786. PubMed ID: 34637370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream infections caused by Enterococcus spp: A 10-year retrospective analysis at a tertiary hospital in China.
    Zheng JX; Li H; Pu ZY; Wang HY; Deng XB; Liu XJ; Deng QW; Yu ZJ
    J Huazhong Univ Sci Technolog Med Sci; 2017 Apr; 37(2):257-263. PubMed ID: 28397040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early alert from the microbiology laboratory improves the outcome of elderly patients with Enterococcus spp. bloodstream infection: Results from a multicentre prospective study.
    Falcone M; Tiseo G; Dentali F; Foglia E; Campanini M; Menichetti F; Mazzone A;
    J Glob Antimicrob Resist; 2019 Sep; 18():139-144. PubMed ID: 30825701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
    Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.
    McBride SJ; Upton A; Roberts SA
    Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):107-14. PubMed ID: 19916034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Observational Study of the Clinical Prognoses of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis.
    Kim D; Lee H; Yoon EJ; Hong JS; Shin JH; Uh Y; Shin KS; Shin JH; Kim YA; Park YS; Jeong SH
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of Enterococcus faecium on Enterococcal bloodstream infections: a 14-year study in a Swiss tertiary hospital.
    Weisser M; Capaul S; Dangel M; Elzi L; Kuenzli E; Frei R; Widmer A
    Infect Control Hosp Epidemiol; 2013 Oct; 34(10):1109-12. PubMed ID: 24018931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid vs glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteraemia: A propensity score matched comparative study.
    Echeverria-Esnal D; Sorli L; Prim N; Conde-Estévez D; Mateu-De Antonio J; Martin-Ontiyuelo C; Horcajada JP; Grau S
    Int J Antimicrob Agents; 2019 Nov; 54(5):572-578. PubMed ID: 31476435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.
    Hayakawa K; Marchaim D; Martin ET; Tiwari N; Yousuf A; Sunkara B; Pulluru H; Kotra H; Hasan A; Bheemreddy S; Sheth P; Lee DW; Kamatam S; Bathina P; Nanjireddy P; Chalana IK; Patel S; Kumar S; Vahia A; Ku K; Yee V; Swan J; Pogue JM; Lephart PR; Rybak MJ; Kaye KS
    Antimicrob Agents Chemother; 2012 May; 56(5):2452-8. PubMed ID: 22354290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterococcal Bacteremia in Children With Malignancies and Following Hematopoietic Stem Cell Transplantation: A 15-Year Single-Center Experience.
    Friedman G; Stepensky P; Abu Ahmad W; Masarwa R; Temper V; Oster Y; Amit S; Averbuch D
    Pediatr Infect Dis J; 2020 Apr; 39(4):318-324. PubMed ID: 31990889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.